Protein neddylation and its alterations in human cancers for targeted therapy.
Protein neddylation and its alterations in human cancers for targeted therapy.
复制标题
蛋白质 neddylation 及其在人类癌症中的改变用于靶向治疗。
DOI:
10.1016/j.cellsig.2018.01.009
复制
发表时间:
2018-04
影响因子:
4.8
通讯作者:
Jia L
中科院分区:
文献类型:
--
作者:
Zhou L;Zhang W;Sun Y;Jia L
Neddylation, a post-translational modification that conjugates an ubiquitin-like protein NEDD8 to substrate proteins, is an important biochemical process that regulates protein function. The best-characterized substrates of neddylation are the cullin subunits of Cullin-RING ligases (CRLs), which, as the largest family of E3 ubiquitin ligases, control many important biological processes, including tumorigenesis, through promoting ubiquitylation and subsequent degradation of a variety of key regulatory proteins. Recently, increasing pieces of experimental evidence strongly indicate that the process of protein neddylation modification is elevated in multiple human cancers, providing sound rationale for its targeting as an attractive anticancer therapeutic strategy. Indeed, neddylation inactivation by MLN4924 (also known as pevonedistat), a small molecule inhibitor of E1 NEDD8-activating enzyme currently in phase I/II clinical trials, exerts significant anticancer effects by inducing cell cycle arrest, apoptosis, senescence and autophagy in a cell-type and context dependent manner. Here, we summarize the latest progresses in the field with a major focus on preclinical studies in validation of neddylation modification as a promising anticancer target.
登录
查看更多内容
影响因子:
--
作者:
Chen P;Hu T;Liang Y;Jiang Y;Pan Y;Li C;Zhang P;Wei D;Li P;Jeong LS;Chu Y;Qi H;Yang M;Hoffman RM;Dong Z;Jia L
通讯作者:
Jia L
影响因子:
13.3
作者:
Carew, Jennifer S.;Nawrocki, Steffan T.;Cleveland, John L.
通讯作者:
Cleveland, John L.
影响因子:
16
作者:
Brownell, James E.;Sintchak, Michael D.;Dick, Lawrence R.
通讯作者:
Dick, Lawrence R.
影响因子:
11.5
作者:
Chen, Ping;Hu, Tao;Jia, Lijun
通讯作者:
Jia, Lijun
影响因子:
14.5
作者:
Bloom, J;Pagano, M
通讯作者:
Pagano, M